Hemifacial spasm: Results of treatment with low dose botulinum toxin injection

Journal of the Medical Association of Thailand

Volumn 87, Issue 10, 2004, Pages 1205-1211

  Suputtitada, Areerat ^a   Phanthumchinda, Kammant ^a   Locharernkul, Chaichon ^a   Suwanwela, Nijasri C ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Botulinum toxin; Hemifacial spasm

Indexed keywords

BOTULINUM TOXIN A;

ADULT; AGED; ARTICLE; BELL PALSY; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; DIPLOPIA; DISEASE DURATION; DRUG EFFICACY; DRUG SAFETY; FACIAL NERVE PARALYSIS; FEMALE; FOLLOW UP; HEART DISEASE; HEMIFACIAL SPASM; HUMAN; HYPERTENSION; LACRIMATION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MASSAGE; ORBICULARIS OCULI MUSCLE; ORBICULARIS ORIS MUSCLE; PROSPECTIVE STUDY; PTOSIS; STROKE; THAILAND; TINNITUS; TREATMENT OUTCOME;

ADULT; AGED; BOTULINUM TOXIN TYPE A; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HEMIFACIAL SPASM; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 8444241188     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Jost W H, Kohl A. Botulinum toxin: evidence - based medicine criteria in blepharospasm and hemifacial spasm. J Neurol 2001; 248 (Suppl1): 1/21-1/24.
2. Elston J S. Indiopathic blepharospasm, hemifacial spasm and therapeutic ptosis induction. In: Moore P, ed. Handbook of botulinum toxin treatment. Cambridge: Blackwell Science, 1995: 90-100.
3. Jannetta PJ, Abbasy M, Maroon JC, Ramos FM, Albin MS, Etiology and definitive microsurgical treatment of hemifacial spasm. J Neurosurg 1977; 47:3 21-8.
4. Alexander GE, Moses H. Carbamazepine for hemifacial spasm. Neurology 1982; 32: 286-7.
5. Barker II FG, Jannetta PJ, Bissonette DJ, Shield PT, Larkins MV, Jho HD. Microvascular decompression for hemifacial spasm. J Neurosurg 1995; 82: 201-10.
6. Berardelli A, Formica A, Mercuri B, Abbruzzese G, Agnoli A, Agostino R, Caraceni T, Carella F, De Fazio G, De Grandis D, et al. Botulinum toxin treatment in treatments with focal dystonia and hemifacial spasm. A multicenter study of the Italian Movement disorder Group. Ital J Neurol Sci 1993; 14: 361-7.
7. Novis SA, De Mattos JP, De Rosso AL. Botulinum toxin in blepharospasm, in hemifacial spasm and in cervical dystonia: results in 33 treatments. Arq Neuropsiquiatr 1995; 553: 403-10.
8. Park YC, Lim JK, Lee DK, Yi SD. Botulinum a toxin treatment of hemifacial spasm and blepharospasm. J Korean Med Sci 1993; 8: 334-40.
9. Jitpimolmard S, Tiamkao S, Laopaiboon M. Long term results of botulinum toxin type A (Dysport) in the treatment of hemifacial spasm: a report of 175 cases. J Neurol Neurosurg Psychiatry 1998; 64: 751-7.
10. Astarloa R, Morales B, Sanchez V, Penafiel N, Rabano J, Olivan J, Garcia de Yebenes J. Focal dystonias and facial hemispasm: treatment with botulinum A toxin. Arch Neurobiol 1991; 54: 210-7.
11. Dutton JJ, Buckley EG. Longterm results and complications of botulinum A toxin in the treatment of blepharospasm. Ophthalmology 1988; 95: 1529-34.
12. Kraft SP, Lang AE. Botulinum toxin injections in the treatment of blepharospasm, hemifacial spasm and eyelid fasciculations. Can J Neurol Sci 1988; 15: 276-80.
13. Poungvarin N, Viriyavejakul A. Two hundred and fifty treatments with hemifacial spasm treated with botulinum toxin injection. J Med Assoc Thai 1992; 75: 199-203.
14. Yoshimura DM, Aminoff MJ, Tami TA, Scott AB. Treatment of hemifacial spasm with botulinum toxin Muscle Nerve 1992; 15: 1045-9.
15. Poewe W, Kleedorfer B. Treatment of essential blepharospasm and hemifacial spasm by local injections of botulinum toxin type A: experiences in 50 treatments. Arch Neurol 1989; 16: 78-82.
16. Boridic GE. Hemifacial spasm: Evaluation and management, with emphasis on botulinum toxin therapy. In:Jankovic J, Hallet M, eds. Therapy with botulinum toxin. New York: Marcel Dekker, 1994: 331-51.
17. Taylor JDN, Kraft SP, Kazdan MS, et al. Treatment of blepharospasm and hemifacial spasm with botulinum A toxin: a conadian multicenter study. Can J Ophthalmol 1991; 26: 133-8.
18. Flanders M, Chin D, Boghen D. Botulinum tosin preferred treatment for hemifacial spasm. Eur Neurol 1993; 33: 316-9.
19. Poungvarin N, Nilanont Y, Prayoonwiwat N, Senanarong V. Hemifacial spasm treated with botulinum toxin injection: A ten-year experience at Siriraj Hospital. Siriraj Hosp Gaz 2001; 53(1): 1-7.
20. Elston JS. The management of blepharospasm and hemifacial spasm. J Neurol 1992; 239: 5-8.
21. Vanden Bergh P, Francart J, Mourin S, et al. Five years experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin. Muscle Nerve 1995; 18: 720-29.
22. Suputtitada A. Managing spasticity in pediatric cerebral palsy using a very low dose of botulinum toxin type A: preliminary report. Am J Phys Med Rehabil 2000: 320-6.
23. Suputtitada A. Three case reports of using botulinum toxin type A in chronic myofascial pain syndromes. J Thai Rehabil 2001; 11(1): 35-41.
24. st ISPRM) at Amsterdam, Netherland, July 7-13, 2001.
25. Suputtitada A. Local botulinum toxin type A injection in the treatment of spastic toes. Am J Phys Med Rehabil 2002; 81: 770-5.
26. Suputtitada A, Phanthumchinda K, Locharernkul C, Suwanwela NC. Treatment of writer's cramp with very low dose botulinum toxin type A at King Chulalongkorn Memorial Hospital. Proceedings of the International Conference 2002: Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins at Hannover, Germany on June 8-11, 2002. Abstract published in N-S Arch Pharmacol 2002; 148 Suppl 2: 365.
27. nd ISPRM) at Prague, Czech Republic, May 18-22, 2003.